Please login to the form below

Not currently logged in
Email:
Password:

Westminster Advisers

This page shows the latest Westminster Advisers news and features for those working in and with pharma, biotech and healthcare.

Latest appointments

  • Westminster Advisers expands health practice Westminster Advisers expands health practice

    Sarah Gullo and Emily Cameron join public affairs specialist agency. London-based Westminster Advisers has expanded its health practice, WA Health, with the appointment of two new associate directors to its ... Dominic Church, managing director at

  • Jenny Ousbey moves from Lexington to Westminster Advisers Jenny Ousbey moves from Lexington to Westminster Advisers

    Public affairs specialist consultancy Westminster Advisers has appointed Jenny Ousbey as its new head of health and a director. ... Dominic Church, Westminster Advisers' managing director, said: “We are absolutely delighted to be welcoming Jenny to the

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

Latest from PMHub

  • WA Communications

    We are public affairs and communications consultants guiding you through knotty business challenges to deliver significant commercial results. The NHS and wider health landscape are ever-changing and increasingly complex. Using deep

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

WHITE PAPER 05: Improving the effectiveness of clinical trial recruitment materials
With exclusive research conducted by COUCH Health, gain insight into clinical trial recruitment materials best practice....
COVID-19: the race to find a vaccine
How biopharma is working to bring an end to the pandemic...
Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy
Global product lead George Kirk hails the triumph of selumetinib, which has just won FDA approval...

Infographics